Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

by Esaú C. João, R. Leavitt Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvèa, Maria de Lourdes B Teixeira, Trevon L. Fuller, Blandina T. Mmbaga, James S. Ngocho, Boniface N. Njau, Avy Violari, Ruth Mathiba, Zaynab Essack, Jose Henrique S. Pilotto, Luis Felipe Moreira, Maria Jose Rolon, Pedro Cahn, Sinart Prommas, Timothy R. Cressey, Kulkanya Chokephaibulkit, Peerawong Werarak, Lauren Laimon, Roslyn Hennessy, Lisa M. Frenkel, Patricia Anthony, Brookie M. Best, George K. Siberry, Mark Mirochnick
Published 2020

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

by Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz, Robert Salata, Peter Mugyenyi, Evelyn Hogg, Linda Wieclaw, Robert Gross, Catherine Godfrey, Sandra W. Cardoso, Aggrey Bukuru, Mumbi Makanga, Sharlaa Faesen, Vidya Mave, Beatrice Wangari Ndege, Sandy Nerette Fontain, Wadzanai Samaneka, Rode Secours, Marije van Schalkwyk, Rosie Mngqibisa, Lerato Mohapi, Javier Valencia, Patcharaphan Sugandhavesa, Esmelda Montalban, Anchalee Avihingsanon, Breno R. Santos, Nagalingeswaran Kumarasamy, Cecilia Kanyama, Robert T. Schooley, John W. Mellors, Carole L. Wallis, Ann C. Collier, B. Grinsztejn, P. N. Mugyenyi, A. Collier, R. Salata, C. Godfrey, E. Hogg, M. Hughes, J. Ritz, L. Wieclaw, T. Sise, J. W. Mellors, C. Wallis, C. V. Fletcher, M. Gandhi, R. Gross, R. T. Schooley, R. Walensky, M. van Schalkwyk, S. Faesen, R. Mngqibisa, J. Valencia, E. Montalban, N. Kumarasamy, C. Kanyama, S. W. Cardoso, B. R. Santos, B. Mansfield, H. Mugerwa, B. W. Ndege, R. Secours, W. Samaneka, D. Kadam, V. Mave, M. Makanga, S. N. Fontain, P. Sugandhavesa, A. Avihingsanon, L. Nakibuuka, H. Nassolo, P. Anthony, V. Kulkarni, M. Nsubuga, J. van Wyk, J. Rooney, Y. van Delft, R. Leavitt, R. Luk, A. Benns, L. Hovind, A. Shahkolahi
Published 2019